Skip to main content
. 2020 Sep 23;10:15568. doi: 10.1038/s41598-020-72453-1

Table 5.

TAVR procedure related complications according to first and next generation TAVR prosthesis.

Complication /Related procedure First generation TAVR NStudies/NPatients Next generation TAVR NStudies/NPatients p value
PM Implantation (%) 17.12 ± 11.64 177/51,104 16.99 ± 9.66 58/11,024 0.681
PVL II–III 12.39 ± 9.38 74/17,877 1.75 ± 2.43 48/7,942 < 0.000
TIA (%) 0.87 ± 1.24 35/18,061 1.95 ± 3.29 7/1,484 0.972
Stroke (%) 2.73 ± 2.49 160/46,931 2.09 ± 2.93 52/9,893 0.009
Myocardial infarction (%) 1.39 ± 2.22 118/42,851 0.45 ± 0.97 42/8,127 < 0.000
Coronary obstruction (%) 0.99 ± 1.47 25/7,314 0.13 ± 0.29 22/3,350 0.004
Vascular complication (%) 11.51 ± 7.23 122/33,242 5.42 ± 4.75 51/7,904 < 0.000
Cardiac Reintervention (%) 1.86 ± 1.28 11/2,705 0.38 ± 0.866 18/3,252 0.002
Surgical replacement (%) 2.54 ± 3.19 59/20,096 0.54 ± 1.55 30/4,983 < 0.000
Balloon (%) 16.73 ± 15.15 40/11,982 12.83 ± 14.12 14/1,109 0.252
Bleeding (%) 9.27 ± 6.12 96/36,200 7.48 ± 6.62 45/9,014 0.049
Death (%) 5.41 ± 4.35 186/55,322 1.47 ± 1.73 54/10,088 < 0.000

Significant p values are indicated in bold.

PM pacemaker, PVL paravalvular leakage, TIA transitory ischemic attack.